1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
2. Drey N, Roderick P, Mullee M, et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-684.
3. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-850.
4. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
6. Balogun RA, Abdel-Rahman EM, Balogun SA, et al. Association of depression and antidepressant use with mortality in a large cohort of patients with nondialysis-dependent CKD. Clin J Am Soc Nephrol 2012;7:1793-1800.
7. Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 2013;84:179-191.
8. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007;14:82-99.
9. Murtagh FE, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med 2007;10:1266-1276.
10. Wu J, Ginsberg JS, Zhan M, et al. Chronic pain and analgesic use in CKD: implications for patient safety. Clin J Am Soc Nephrol 2015;10:435-442.
11. Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007;167:676-683.
12. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-184.
13. Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 2007;25:9-14.
14. Hassan Y, Al-Ramahi RJ, Aziz NA, et al. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother 2009;43:1598-1605.
15. Institute of Medicine Committee on Identifying and Preventing Medication Errors. Preventing Medication Errors: Quality Chasm Series. Washington, DC: The National Academies Press; 2006.
16. Breton G, Froissart M, Janus N, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function-the Three-City population-based study. Nephrol Dial Transplant 2011;26:2852-2859.
17. Ingrasciotta Y, Sultana J, Giorgianni F, et al. The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS One 2014;9:e89072.
18. Mark TL, Levit KR, Buck JA. Datapoints: psychotropic drug prescriptions by medical specialty. Psychiatr Serv 2009;60:1167.
19. Goodwin R, Gould MS, Blanco C, et al. Prescription of psychotropic medications to youths in office-based practice. Psychiatr Serv 2001;52:1081-1087.
20. Katon W, von Korff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76.
21. Cole S, Raju M, Barrett J, et al. The MacArthur Foundation Depression Education Program for Primary Care Physicians: background and rationale. Gen Hosp Psychiatry 2000;22:299-358.
22. Eisenberg L. Treating depression and anxiety in primary care. Closing the gap between knowledge and practice. N Engl J Med 1992;326:1080-1084.
23. Kroenke K, Taylor-Vaisey A, Dietrich AJ, et al. Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature. Psychosomatics 2000;41:39-52.
24. Schurman RA, Kramer PD, Mitchell JB. The hidden mental health network. Treatment of mental illness by nonpsychiatrist physicians. Arch Gen Psychiatry 1985;42:89-94.
25. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
26. Long CL, Raebel MA, Price DW, et al. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother 2004;38:853-858.
27. Ash JS, Sittig DF, Guappone KP, et al. Recommended practices for computerized clinical decision support and knowledge management in community settings: a qualitative study. BMC Med Inform Decis Mak 2012;12:6.
28. Physicians’ Desk Reference, 67th ed. Montvale, NJ: PDR Network, 2012.
31. Ryan NM, Isbister GK. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol (Phila) 2015;53:545-550.
32. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13S-24S.
33. Cole MG, McCusker J, Elie M, et al. Systematic detection and multidisciplinary care of depression in older medical inpatients: a randomized trial. CMAJ 2006;174:138-144.
34. Vadivelu N, Mitra S, Kaye AD, et al. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best Pract Res Clin Anaesthesiol 2014;l28:91-101.
35. Nasca TJ, Philibert I, Brigham T, et al. The next GME accreditation system-rationale and benefits. N Engl J Med 2012;366:1051-1056.
36. Clinical Guideline Subcommittee on Low Back Pain, American Osteopathic Association. American Osteopathic Association guidelines for osteopathic manipulative treatment (OMT) for patients with low back pain. J Am Osteopath Assoc 2010;110:653-666.
37. Egle JP, Smeenge DM, Kassem KM, et al. The Internet School of Medicine: use of electronic resources by medical trainees and the reliability of those resources. J Surg Educ 2015;72:316-320.
38. Agrawal V, Ghosh AK, Barnes MA, et al. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. Am J Kidney Dis 2008;52:1061-1069.
39. Bartels C, Goetz S, Ward E, et al. Internal medicine residents’ perceived ability to direct patient care: impact of gender and experience. J Womens Health (Larchmt) 2008;17:1615-1621.
40. Nicolai J, Demmel R. The impact of gender stereotypes on the evaluation of general practitioners’ communication skills: an experimental study using transcripts of physician-patient encounters. Patient Educ Couns 2007;69:200-205.
41. Lagro-Janssen AL. Medicine is not gender-neutral: influence of physician sex on medical care. Ned Tijdschr Geneeskd 2008;152:1141-1145.
42. Bylund CL, Makoul G. Empathic communication and gender in the physician-patient encounter. Patient Educ Couns 2002;48:207-216.
43. Norcini JJ, Boulet JR, Dauphinee WD, et al. Evaluating the quality of care provided by graduates of international medical schools. Health Aff (Millwood) 2010;29:1461-1468.
44. Jordan JT, Sellner J, Struhal W, et al. International issues: obtaining an adult neurology residency position in the United States: an overview. Neurology 2014;82:e112-115.
45. Smith MA, Cox ED, Bartell JM. Overprescribing of lipid lowering agents. Qual Saf Health Care 2006;15:251-257.
46. Accreditation Council for Graduate Medical Education. ACGME Data Resource Book, Academic Year 2012-2013. Chicago: ACGME 2013.